Full Text (PDF)
Review Article

Conventional s ransdermal Drug Delivery System

Sandhiya V , Sandhiya  , Praveen Kumar M , Prasanth Ra C N , Nirmal P! , Mano A# , Suhai$ I&

Author Information

Licence:




RFP Journal of Dermatology 7(1):p 17-26, January-Febuary 2022. | DOI:

How Cite This Article:

Sandhiya V, Praeen KumarM, Prasanth Raj C N, et al. Conentional Vs Transdermal Drug Deliery System. RFP Journal of
Dermatology2022&(1)
 


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

ABS RAC
Manymedicationsarenowadministeredorally&howeertheyarenotaseffectieas
theyshould e.Beyondthelocalapplicationsite,transdermaldelierytechnology
is eing e*ploredtotreatawide range ofdiseases.Becauseof reducedfirstpass
meta olism,aoidanceofanadersegastrointestinalenironment,andthepotential
toproidee*tendedandregulateddrugdeliery,transdermaldrugadministration
offerssu stantial enefitsoeroraltreatment.Transdermaldrugdelierysystems
(TDDS)aretopically appliedpatchesthatreleasemedicationsfor systemiceffects
atapredeterminedandregulatedrate.Itworks yputting amedicationinsidea
patchandwearingitforalongtimeontheskin.Asaresult,asteadyconcentration
ofmedication remains inthe loodstreamfor an e*tendedperiod oftime. TDDS
products include Scopolamine, Nicotine, Testosterone, Fentanyl, and Clonidine.
Numerousactiecompoundswitharia lemolecularsi3eandstructurecannot e
maintainedintransdermalform,despitetheirmany enefits.
Key(ords)Transdermalpatch,Skin,Permeationpathways,Matri*.
 


References

No records found.


About this article


Cite this article

Sandhiya V, Praeen KumarM, Prasanth Raj C N, et al. Conentional Vs Transdermal Drug Deliery System. RFP Journal of
Dermatology2022&(1)
 


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Monday 26 January 2026, 18:55:47 (IST)


35

Accesses

0
4
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share